Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ... British journal of pharmacology 174 (11), 1325-1348, 2017 | 1099 | 2017 |
An update on pharmacological potential of boswellic acids against chronic diseases NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ... International journal of molecular sciences 20 (17), 4101, 2019 | 206 | 2019 |
Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets K Banik, AM Ranaware, V Deshpande, SP Nalawade, G Padmavathi, ... Pharmacological research 144, 192-209, 2019 | 157 | 2019 |
Magnolol: A neolignan from the magnolia family for the prevention and treatment of cancer AM Ranaware, K Banik, V Deshpande, G Padmavathi, NK Roy, G Sethi, ... International journal of molecular sciences 19 (8), 2362, 2018 | 144 | 2018 |
Tocotrienols: The promising analogues of vitamin E for cancer therapeutics BL Sailo, K Banik, G Padmavathi, M Javadi, D Bordoloi, ... Pharmacological Research 130, 259-272, 2018 | 139 | 2018 |
ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment A Devi Khwairakpam, M Singh Shyamananda, B Lalduhsaki Sailo, ... Current drug targets 16 (2), 156-163, 2015 | 138 | 2015 |
Butein in health and disease: A comprehensive review G Padmavathi, NK Roy, D Bordoloi, F Arfuso, S Mishra, G Sethi, ... Phytomedicine 25, 118-127, 2017 | 132 | 2017 |
Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016 | 110 | 2016 |
Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases AB Kunnumakkara, K Banik, D Bordoloi, C Harsha, BL Sailo, ... Frontiers in pharmacology 9, 686, 2018 | 109 | 2018 |
Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression G Padmavathi, K Banik, J Monisha, D Bordoloi, B Shabnam, F Arfuso, ... Cancer letters 432, 260-271, 2018 | 106 | 2018 |
Potential of butein, a tetrahydroxychalcone to obliterate cancer G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ... Phytomedicine 22 (13), 1163-1171, 2015 | 88 | 2015 |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ... Cancers 10 (7), 228, 2018 | 81 | 2018 |
Acorus calamus: a bio-reserve of medicinal values AD Khwairakpam, YD Damayenti, A Deka, J Monisha, NK Roy, ... Journal of basic and clinical physiology and pharmacology 29 (2), 107-122, 2018 | 75 | 2018 |
Cyperus rotundus L. prevents non-steroidal anti-inflammatory drug-induced gastric mucosal damage by inhibiting oxidative stress D Thomas, S Govindhan, EC Baiju, G Padmavathi, AB Kunnumakkara, ... Journal of basic and clinical physiology and pharmacology 26 (5), 485-490, 2015 | 71 | 2015 |
Sorcin a potential molecular target for cancer therapy B Shabnam, G Padmavathi, K Banik, S Girisa, J Monisha, G Sethi, L Fan, ... Translational Oncology 11 (6), 1379-1389, 2018 | 69 | 2018 |
TIPE family of proteins and its implications in different chronic diseases D Bordoloi, K Banik, B Shabnam, G Padmavathi, J Monisha, F Arfuso, ... International journal of molecular sciences 19 (10), 2974, 2018 | 68 | 2018 |
Specific targeting of Akt kinase isoforms: Taking the precise path for prevention and treatment of cancer N Kishor Roy, D Bordoloi, J Monisha, G Padmavathi, J Kotoky, R Golla, ... Current Drug Targets 18 (4), 421-435, 2017 | 60 | 2017 |
NF-κB blockers gifted by mother nature: Prospectives in cancer cell chemosensitization J Monisha, G Padmavathi, NK Roy, A Deka, D Bordoloi, A Anip, ... Current pharmaceutical design 22 (27), 4173-4200, 2016 | 58 | 2016 |
Potential application of zerumbone in the prevention and therapy of chronic human diseases YP Singh, S Girisa, K Banik, S Ghosh, P Swathi, M Deka, G Padmavathi, ... Journal of Functional Foods 53, 248-258, 2019 | 56 | 2019 |
Nuclear factor kappa B: a potential target to persecute head and neck cancer J Monisha, N Kishor Roy, D Bordoloi, A Kumar, R Golla, J Kotoky, ... Current drug targets 18 (2), 232-253, 2017 | 53 | 2017 |